Merck (MRK) Interest & Investment Income (2011 - 2013)

Merck (MRK) reported Interest & Investment Income of $57.0 million for Q1 2013, up 3.64% year-over-year from $55.0 million in Q1 2012, and up 3.64% quarter-over-quarter from $55.0 million in Q4 2012.

Merck (MRK) Interest & Investment Income (2011 - 2013) Analysis & Trends

Merck (MRK) has 3 years of Interest & Investment Income data on file, last reported at $57.0 million in Q1 2013.

  • Interest & Investment Income for Q1 2013 came in at $57.0 million, up 3.64% year-over-year; the trailing twelve-month figure through Mar 2013 was $214.0 million (changed N/A YoY), and the FY2012 annual result was $1.8 billion, changed 0.0% from the prior year.
  • Interest & Investment Income improved to $57.0 million in Q1 2013 per MRK's latest filing, from $55.0 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $57.0 million in Q1 2013 and troughed at $32.0 million in Q3 2011.
  • A 3-year average of $48.2 million and a median of $51.0 million in 2012 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2012 and 2013: Interest & Investment Income jumped 46.88% in 2012, then gained 3.64% in 2013.
  • A 3-year view of Interest & Investment Income shows it stood at $43.0 million in 2011, then gained by 27.91% to $55.0 million in 2012, then grew by 3.64% to $57.0 million in 2013.
  • Business Quant data shows MRK's Interest & Investment Income at $57.0 million in Q1 2013, $55.0 million in Q4 2012, and $47.0 million in Q3 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 29.66 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 229.00 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -645.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2013 57.00 Mn
Dec 31, 2012 55.00 Mn
Sep 30, 2012 47.00 Mn
Mar 31, 2012 55.00 Mn
Dec 31, 2011 43.00 Mn
Sep 30, 2011 32.00 Mn